Coronary IVL News & Take-Aways for U.S. Physicians from TCT 2022
Shockwave IVL
205 videos
Simplify your procedures with Intravascular Lithotripsy (IVL) by safely modifying intimal and medial calcium to achieve optimal outcomes while minimising trauma, complications and costs due to its...
Read More
Simplify your procedures with Intravascular Lithotripsy (IVL) by safely modifying intimal and medial calcium to achieve optimal outcomes while minimising trauma, complications and costs due to its unique MOA.
Prior to use, please reference the instructions for use and important safety information: https://shockwavemedical.com/important-safety-information-universal/
Discover more at ShockwaveIVL.com
Speakers
Dr. Lansky is a Professor of Medicine in the section of Cardiology at the Yale School of Medicine, and is a...
Dr. Lansky is a Professor of Medicine in the section of Cardiology at the Yale School of Medicine, and is a practicing cardiologist at Yale-New Haven Hospital in New Haven, CT. She has dedicated her career to leading clinical and angiographic evaluations of more than 500 clinical trials in a broad range of ischemic cardiovascular therapeutic areas, including pharmacologic and interventional device trials, many of which are landmark trials in the field and/or leading to FDA approval in the United States. She has served as the principal investigator on numerous national and international imaging studies, devices, DES, and neuroprotection trials. Dr. Lansky has authored and coauthored over 500 academic peer-reviewed manuscripts in the fields of interventional cardiology, angiography, and women’s cardiovascular health. She chaired the American Heart Association Statement on Interventions in Women and most recently the Academic Research Consortium defining Neurologic Endpoints in clinical cardiovascular trials.
Robert W. Yeh, MD MSc is Associate Chief of Interventional Cardiology at the Beth Israel Deaconess Medical Center and...
Robert W. Yeh, MD MSc is Associate Chief of Interventional Cardiology at the Beth Israel Deaconess Medical Center and the Katz-Silver Associate Professor of Medicine at Harvard Medical School. He is an expert in complex coronary intervention, including chronic total occlusion PCI. He is also the founding Director the Smith Center for Outcomes Research at BIDMC.
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional...
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.
Start a conversation